NEVIA
Live / Allowed — Notice of allowance issued (as of 03 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 13 May 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99183535
- Mark type
- Stylized text
- Filed
- 13 May 2025
- Published for opposition
- 09 Dec 2025
- Attorney of record
- Brooks Lindsay
Goods and services
- Class 009 — Scientific and electric apparatus: Downloadable mobile application software for providing and optimizing neuromodulation therapy for gut health; Downloadable computer software using artificial intelligence (AI) technology for managing gastrointestinal and inflammatory conditions through transcutaneous cervical vagus nerve stimulation (tcVNS) and transcutaneous auricular vagus nerve stimulation (taVNS); Downloadable computer software for providing and tracking brain-gut axis treatment sessions, providing personalized gut health recommendations, monitoring progress, and interfacing with wearable medical devices
- Class 010 — Medical apparatus: Non-invasive wearable gut-health medical devices for therapeutic neuromodulation, namely, devices that apply simultaneous transcutaneous cervical vagus nerve stimulation (tcVNS) and transcutaneous auricular vagus nerve stimulation (taVNS) for the treatment of inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), Crohn's Disease, and ulcerative colitis; Medical apparatuses, namely, biofeedback sensors using artificial intelligence (AI) technology featuring dual-modality vagus nerve stimulation for modulating immune function and reducing gut inflammation
- Class 042 — Scientific and technological services: Providing online non-downloadable software using artificial intelligence (AI) technology for managing gastrointestinal and inflammatory conditions through transcutaneous cervical vagus nerve stimulation (tcVNS) and transcutaneous auricular vagus nerve stimulation (taVNS); Providing online non-downloadable software for providing and tracking braingut axis treatment sessions, providing personalized gut health recommendations, monitoring progress, and interfacing with wearable medical devices
- Class 044 — Medical, beauty and agricultural services: Providing online digital medical services in the field of gastroenterology, namely, personalized therapeutic support in the nature of remote monitoring for inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) delivered through guided neuromodulation therapy using artificial intelligence (AI) technology for medical diagnosis and treatment purposes; Medical consultation and monitoring services for individuals with gut conditions using transcutaneous cervical and auricular vagus nerve stimulation delivered via wearable devices and mobile applications; Healthcare services, namely, gut-health treatment featuring the integration of bioelectronic therapy, symptom tracking, and real-time treatment adjustment to support immune modulation and inflammation reduction
Owner
- Enteronova Medical Technologies Inc., Bellevue, WA, US
- Enteronova Medical Technologies Inc., Bellevue, WA, US
Prosecution history
- 03 Feb 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Dec 2025 — PUBLISHED FOR OPPOSITION
- 03 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Nov 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 05 Nov 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 05 Nov 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 30 Sept 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 30 Sept 2025 — NON-FINAL ACTION E-MAILED
- 30 Sept 2025 — NON-FINAL ACTION WRITTEN
- 26 Sept 2025 — ASSIGNED TO EXAMINER
- 23 Sept 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 13 May 2025 — APPLICATION FILING RECEIPT MAILED
- 13 May 2025 — NEW APPLICATION ENTERED